Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Cash from Financing Activities (2022 - 2025)

Neuraxis' Cash from Financing Activities history spans 4 years, with the latest figure at -$183808.0 for Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 71.43% year-over-year to -$183808.0; the TTM value through Sep 2025 reached $10.4 million, up 59.65%, while the annual FY2024 figure was $9.7 million, 47.85% up from the prior year.
  • Cash from Financing Activities for Q3 2025 was -$183808.0 at Neuraxis, down from $5.5 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $5.5 million in Q2 2025 and bottomed at -$183808.0 in Q3 2025.
  • The 4-year median for Cash from Financing Activities is $807543.0 (2022), against an average of $1.8 million.
  • The largest annual shift saw Cash from Financing Activities skyrocketed 419.48% in 2024 before it tumbled 105.17% in 2025.
  • A 4-year view of Cash from Financing Activities shows it stood at $510009.0 in 2022, then surged by 284.88% to $2.0 million in 2023, then soared by 164.61% to $5.2 million in 2024, then tumbled by 103.54% to -$183808.0 in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Cash from Financing Activities are -$183808.0 (Q3 2025), $5.5 million (Q2 2025), and -$69845.0 (Q1 2025).